Select Page

The Plasma Proteins Market in Canada — 2019/2020

 

The report on The Plasma Proteins Market in Canada – 2019/20 updates the same title published every two years. Two non-profit organizations (Canadian Blood Services and Héma-Québec) distribute most plasma and recombinant products, which distinguishes the market from other countries’. The effects of recent regulatory measures and on-going, economic and health care issues are examined in this report, which also provides sales data of all the major plasma-derived and recombinant proteins including non-factor hemophilia products.

The report is delivered electronically (Excel and/or pdf files). For more information or to order this report, please contact Marketing Research Bureau at inf0@marketingresearchburau.com

THE PLASMA PROTEINS MARKET IN CANADA — 2019/2020

TABLE OF CONTENTS

 

EXECUTIVE SUMMARY

HEALTH CARE ENVIRONMENT

BLOOD AND PLASMA COLLECTIONS

Historical Development
Whole Blood Collections
Plasma Procurement Plans
Project Recovery
Controversy around the Remuneration of Plasma Donations
Canadian Blood Services (CBS)
Production and Distribution of Blood Components and Plasma Products
Future Plans
Héma-Québec (HQ)
Production and Distribution of Blood Components and Plasma Products
Canadian Plasma Resources (CPR)

PLASMA FRACTIONATION

Historical Development
Contracts for Fractionation, Plasma products and Recombinant FVIII and FIX
Emergent BioSolutions (formerly Cangene Corporation) – Saol Therapeutics
Liminal Biosciences (formerly Prometic Life Sciences)
Evolve Biologics (formerly Therapure Biopharma)
Green Cross Canada (Now part of Grifols)

MARKET OVERVIEW

INTRAMUSCULAR IMMUNE GLOBULIN

Polyvalent Intramuscular Immune Globulin (IMIG)
Rho(D) Immune Globulin
Hepatitis B Immune Globulin
Rabies Immune Globulin
Varicella Zoster Immune Globulin
Cytomegalovirus Hyperimmune Globulin

POLYVALENT IMMUNE GLOBULIN (IVIG & SCIG)

Intravenous Polyvalent Immune Globulin (IVIG)
Subcutaneous Polyvalent Immune Globulin (SCIG)
Canadian Self-Sufficiency
2020 and COVID19 Effects on Canadian IG market

ALBUMIN MARKET

HEMOPHILIA CARE AND COAGULATION

MARKET

Demographic Data on Hemophilia
Hemophilia Treatment
Hemophilia A Market (FACTOR VIII)
Hemophilia B Market (FACTOR IX) Market
Von Willebrand Disease Market
Inhibitor Care Market
Factor VII
Factor XI
Factor XIII

OTHER PLASMA PRODUCTS

Prothrombin Complex Concentrate Market (PCC)
Alpha-1 Antitrypsin (AAT)
Antithrombin III
C1 Esterase Inhibitor (C1-INH)
Fibrinogen
Protein C
Fibrin Sealant
Plasminogen
Hemin

PRICING AND DISTRIBUTION

MARKET TRENDS AND THREE-YEAR FORECAST

LIST OF MAJOR COMPANIES & ORGANIZATIONS